We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
76 hedge funds and large institutions have $134M invested in scPharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
380% more call options, than puts
Call options by funds: $753K | Put options by funds: $157K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4.4% less ownership
Funds ownership: 78.57% → 74.17% (-4.4%)
6% less funds holding
Funds holding: 81 → 76 (-5)
14% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 29
24% less capital invested
Capital invested by funds: $177M → $134M (-$42.4M)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Holders
76
Holders Change
-5
Holders Change %
-6.17%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
25
Reduced
29
Closed
15
Calls
$753K
Puts
$157K
Net Calls
+$596K
Net Calls Change
-$268K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.45M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.58M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.12M |
| 5 |
Renaissance Technologies
New York
|
+$1.09M |
Top Sellers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$4.31M |
| 2 |
SC
Stempoint Capital
New York
|
-$3.56M |
| 3 |
JFG
Jefferies Financial Group
New York
|
-$3.13M |
| 4 |
JGC
J. Goldman & Co
New York
|
-$1.6M |
| 5 |
Walleye Capital
New York
|
-$1.58M |
